Univercells SA, a technology company dedicated to delivering innovative and cost-effective biomanufacturing solutions, today announces that it has received a grant from the Walloon Region. Pierre-Yves Jeholet, Vice-President and Minister of Economic Affairs, Industry, Research Innovation, Digital, Employment and training in the Walloon government, has granted the company EUR 2.4M (USD 2.9M). This funding will enable the company to launch a program aimed at developing its innovative protein platform, paving the way for the cost-effective production of biosimilars. The platform will enable production units to be deployed anywhere in the world, providing access to high-quality biologics independent of location.
The new generation of biologic medicines represents significant progress in healthcare, successfully addressing oncology, auto-immune and rare diseases. However, their prohibitive costs and limited supply lead to unequal access around the world, preventing wide coverage.
The increasing demand for affordable biologics calls for adapted production capacities, capable of drastic cost containment for a significant impact on the commercial price.